Chief Scientist of Beisheng
Dr. Li Ming

●Doctor of Medicine, Hokkaido University School of Medicine, Japan
●PhD in Molecular Biology, University of Wales, UK
●Senior Scientific Director, Cambridge Laboratory, UK
●Postdoctoral Researcher at Southwest Medical Center, University of Texas, USA
●Research Director of the Department of Cardiology, Faculty of Medicine, The Chinese University of Hong Kong
●Led and guided six research and development teams, including Professor Craig Mell0, a 2006 Nobel laureate, and American Academy of Sciences member Olson, among others
●Registered as a Class I new drug (HBI-3802) with the US FDA